Saturday, February 14, 2026
Business Honor
.webp)
| Company | Management | Description |
| PBS Biotech www.pbsbiotech.com |
Brian Lee, Ph.D. Founder & CEO |
PBS Biotech is a leading provider of scalable bioreactor solutions for cell therapy manufacturing. Established with a focus on advancing therapeutic cell production, the company is recognized for its innovative vertical-wheel bioreactor technology. With a commitment to quality and regulatory compliance, PBS Biotech supports the development and commercialization of life-saving cell therapies for a variety of therapeutic applications. |
| Celmatix www.celmatix.com |
Piraye Yurttas Beim, PhD Founder & CEO |
Celmatix is a pioneering preclinical-stage biotechnology company focused on transforming women's lives by improving ovarian health. With a mission to decode ovarian function and address the root causes of hormonal health issues, Celmatix leverages cutting-edge science to develop innovative treatments for conditions like Polycystic Ovary Syndrome (PCOS), endometriosis, and ovarian senescence. Its data-driven, multi-omics approach to drug discovery is setting new standards in women’s healthcare, bridging critical gaps in treatment options for millions worldwide. |
| Cellares www.cellares.com |
Fabian Gerlinghaus Co-Founder & CEO |
Cellares is a leading provider of integrated cell therapy manufacturing solutions, specializing in high-throughput, scalable platforms designed to meet global patient demand. Established with a focus on Industry 4.0 technologies, Cellares is recognized for its innovative approach to automating cell therapy production, ensuring precision and efficiency across the entire process. |
| Volastra Therapeutics www.volastratx.com |
Charles Hugh-Jones M.D., FRCP CEO |
Volastra Therapeutics is a clinical-stage biotechnology company at the forefront of innovation in cancer care. Focused on chromosomal instability (CIN), a hallmark of cancer biology, the company is developing groundbreaking therapies to address treatment-resistant cancers. With its proprietary CINtech platform, Volastra combines advanced data science, AI-driven insights, and cutting-edge screening technologies to identify novel therapeutic targets. Its pipeline includes differentiated KIF18A inhibitors and immune activation strategies, offering precision oncology solutions that exploit the vulnerabilities of chromosomally unstable cancer cells. |
| Enable Biosciences www.enablebiosciences.com |
Carolyn Bertozzi PhD Co-Founder and Chair |
Enable Biosciences focuses on early detection of autoimmune diseases, leveraging its innovative diagnostic technologies. The company's predictive tools, including the ADAP assay, are advancing the ability to identify risks for conditions like Type 1 Diabetes long before symptoms manifest. |